# Title
Human B-Species
hepatic O
cytochrome B-Gene
P450 I-Gene
2C9 I-Gene
catalyzes O
the O
rate-limiting O
pathway O
of O
torsemide B-Chemical
metabolism. O

# Abstract
Tolyl B-Chemical
methylhydroxylation O
is O
the O
rate-limiting O
step O
in O
the O
elimination O
of O
torsemide, B-Chemical
a O
newly O
developed O
diuretic, O
in O
humans B-Species
in O
vivo. O
Kinetic O
and O
inhibitor O
studies O
with O
human B-Species
liver O
microsomes O
and O
complementary O
DNA-expressed O
enzyme O
were O
performed O
to O
identify O
the O
cytochrome O
P450 O
(CYP) O
isoform O
responsible O
for O
torsemide B-Chemical
tolyl B-Chemical
methylhydroxylation O
to O
predict O
factors O
that O
might O
alter O
clearance O
in O
patients B-Species
receiving O
torsemide. B-Chemical
As O
in O
vivo, O
tolyl B-Chemical
methylhydroxylation O
was O
the O
major O
biotransformation O
pathway O
in O
human B-Species
liver O
microsomes. O
Microsomal O
tolyl B-Chemical
methyl-hydroxylation O
kinetics O
followed O
Michaelis-Menten O
kinetics, O
with O
the O
mean O
apparent O
Km O
for O
the O
reaction O
being O
11.2 O
+ O
- O
1.3 O
microM. O
The O
microsomal O
reaction O
was O
almost O
completely O
abolished O
by O
the O
specific O
CYP2C9 B-Gene
inhibitor O
sulfaphenazole B-Chemical
and O
was O
inhibited O
competitively O
by O
the O
alternative O
CYP2C9 B-Gene
substrate O
tolbutamide. B-Chemical
Torsemide B-Chemical
tolyl B-Chemical
methylhydroxylase O
activity O
in O
microsomes O
from O
16 O
human B-Species
livers O
correlated O
significantly O
(rs O
= O
.81-.88) O
with O
tolbutamide B-Chemical
and O
phenytoin B-Chemical
hydroxylation, O
both O
CYP2C9-mediated O
reactions. O
Complementary O
DNA-expressed O
CYP2C9 B-Gene
catalyzed O
torsemide B-Chemical
tolyl B-Chemical
methylhydroxylation O
with O
an O
apparent O
Km O
(23 O
microM) O
similar O
to O
that O
observed O
for O
human B-Species
liver O
microsomes O
and O
the O
IC50 O
values O
for O
sulfaphenazole B-Chemical
inhibition O
of O
the O
reaction O
were O
essentially O
identical O
for O
the O
two O
enzyme O
sources. O
Taken O
together, O
these O
data O
demonstrate O
that O
human B-Species
hepatic O
torsemide B-Chemical
tolyl B-Chemical
methylhydroxylation O
is O
catalyzed O
predominantly, O
if O
not O
solely, O
by O
CYP2C9. B-Gene
The O
implications O
of O
this O
finding O
for O
the O
regulation O
of O
torsemide B-Chemical
metabolism O
in O
vivo O
are O
discussed. O